| Decision |
Title |
Relevant
article(s) |
Page |
| VIII/1 |
Ratification of the Vienna Convention, the
Montreal Protocol and its Amendments |
16 |
366 |
| VIII/2 |
Data and information provided by the Parties
in accordance with Articles 7 and 9 of the Montreal Protocol |
7 |
208 |
| VIII/3 |
Membership of the Implementation Committee |
8 |
222 |
| VIII/4 |
Replenishment of the Multilateral Fund and
three-year rolling business plan for 1997-1999 |
10 |
312 |
| VIII/5 |
Actions to improve the functioning of the
Financial Mechanism |
10 |
332 |
| VIII/6 |
Contributions to the Multilateral Fund |
10 |
313 |
| VIII/7 |
Measures taken to improve the Financial Mechanism
and technology transfer |
10, 10A |
333, 339 |
| VIII/8 |
Membership of the Executive Committee of
the Multilateral Fund |
10 |
323 |
| VIII/9 |
Essential use nominations for Parties not
operating under Article 5 for controlled substances for 1997 through
2002 |
2 |
99 |
| VIII/10 |
Actions by Parties not operating under Article
5 to promote industry’s participation on a smooth and efficient
transition away from CFC‑based MDIs |
2 |
107 |
| VIII/11 |
Measures to facilitate a transition by a
Party not operating under Article 5 from CFC‑based MDIs |
2 |
108 |
| VIII/12 |
Information gathering on a transition to
non-CFC treatments for asthma and chronic obstructive pulmonary disease
for Parties not operating under Article 5 |
2 |
108 |
| VIII/13 |
Uses and possible applications of hydrochlorofluorocarbons
(HCFCs) |
2 |
124 |
| VIII/14 |
Further clarification of the definition of “Bulk
substances” under decision I/12A |
1 |
75 |
| VIII/15 |
Control of trade in methyl bromide with non-Parties |
4 |
158 |
| VIII/16 |
Critical agricultural uses of methyl bromide |
2 |
136 |
| VIII/17 |
Availability of halons for critical uses |
2 |
119 |
| VIII/18 |
List of products containing controlled substances
in Group II of Annex C (Hydrobromofluorocarbons) of the Protocol |
4 |
158 |
| VIII/19 |
Organization and functioning of the Technology
and Economic Assessment Panel |
6 |
190 |
| VIII/20 |
Illegal imports and exports of controlled
substances |
4B |
165 |
| VIII/21 |
Revised formats for reporting data under
Article 7 of the Protocol |
7 |
201 |
| VIII/22 |
Compliance with the Montreal Protocol by
Latvia |
8 |
268 |
| VIII/23 |
Compliance with the Montreal Protocol by
Lithuania |
8 |
274 |
| VIII/24 |
Non-compliance by the Czech Republic with
the halon phase-out by 1994 |
8 |
253 |
| VIII/25 |
Compliance with the Montreal Protocol by
the Russian Federation |
8 |
287 |
| VIII/26 |
Exports of ozone-depleting substances and
products containing ODS |
4B |
162 |
| VIII/27 |
Co-Chairs of the Open-ended Working Group
of the Parties to the Montreal Protocol |
11 |
348 |
| VIII/28 |
Financial Matters: financial report and budgets |
13 |
354 |
| VIII/29 |
Application of Georgia for developing country
status under the Montreal Protocol |
5 |
174 |
| VIII/30 |
Ninth Meeting of the Parties to the Montreal
Protocol |
11 |
342 |
| |
|
|
|
| Annex |
Title |
Section of
the Handbook |
Page |
| I |
Multilateral Fund: scale of 1997-1999 contributions |
(not included) |
| II |
Recommended nominations for essential use
exemptions |
3.2 |
387 |
| III |
Recommended adjustments to quantities approved
earlier for essential uses (reflected in the essential
use approvals of the Seventh Meeting of the Parties, Annex VI - see Section 3.2) |
(not included) |
| IV |
Reporting accounting framework for essential
uses other than laboratory and analytical applications |
3.2 |
387 |
| V |
Terms of reference of the Technology and
Economic Assessment Panel (TEAP) |
3.3 |
396 |
| VI |
Trust Fund for the Montreal Protocol: scale
of 1997-1998 contributions |
(not included) |
| VII |
Trust Fund for the Montreal Protocol: budgets
for 1996, 1997 and 1998 |
(not included) |
| VIII |
Note on the status of the Multilateral Fund |
(not included) |